Results 1 to 10 of about 20,494 (217)

Domperidone‐induced pityriasis rosea‐like drug eruption [PDF]

open access: greenClinical Case Reports, 2022
Pityriasis rosea is a common, acute, self limiting inflammatory skin disease. Pityriasis rosea‐like eruptions (PR‐LE) have been reported after drugs. The clinical presentation of PR‐LE can be distinguished from pityriasis rosea.
Sarra Saad   +3 more
doaj   +5 more sources

Pityriasis Rosea Induced by COVID-19 Vaccination [PDF]

open access: yesEuropean Journal of Case Reports in Internal Medicine, 2022
It is increasingly recognized that SARS-CoV-2 infection and COVID-19 vaccines have been associated with skin disorders, including pityriasis rosea. It has been reported that pityriasis rosea has been triggered by several vaccines, as a rare side-effect ...
Elina Khattab   +2 more
doaj   +7 more sources

Manifestation of pityriasis rosea and pityriasis rosea‐like eruptions after Covid‐19 vaccine: A systematic review [PDF]

open access: yesImmunity, Inflammation and Disease, 2023
Background: After introducing Covid‐19 vaccines, a few side effects were reported, pityriasis rosea being one of them. Therefore, this study will systematically review its manifestation afteradministration.Methods: Databases were searched, covering a ...
Iman Khan   +5 more
doaj   +3 more sources

Pityriasis Rosea and Pityriasis Rosea-like Eruption Following COVID-19 Vaccinations: Case Series from Oman [PDF]

open access: yesOman Medical Journal, 2023
To mitigate the impact of the COVID-19 pandemic, several vaccines have been developed and administered to the public since 2021. A spectrum of cutaneous reactions has been reported among some of the vaccinated individuals.
Iman Al Hatmi   +4 more
doaj   +3 more sources

A Case of Persistent Pityriasis Rosea Successfully Treated by a Short Course of Therapy with Abrocitinib [PDF]

open access: yesClinical, Cosmetic and Investigational Dermatology
Hao Wu, Qing-Jie Ji, Yu-Yang Xu, Jian-Wei Zhu Department of Dermatology, Quzhou TCM Hospital at the Junction of Four Provinces Affiliated to Zhejiang Chinese Medical University, Quzhou, People’s Republic of ChinaCorrespondence: Jian-Wei Zhu, Email zjwmed@
Wu H, Ji QJ, Xu YY, Zhu JW
doaj   +3 more sources

Pityriasis Rosea and Pityriasis Rosea-Like Eruption Following COVID-19 Vaccination: A Narrative Review [PDF]

open access: yesClinical, Cosmetic and Investigational Dermatology
Luca Potestio,* Fabrizio Martora,* Sara Cacciapuoti, Matteo Megna, Alessia Villani, Angelo Ruggiero Section of Dermatology - Department of Clinical Medicine and Surgery, University of Naples Federico II, Naples, Italy*These authors ...
Potestio L   +5 more
doaj   +3 more sources

Dupilumab-induced pityriasis rosea [PDF]

open access: yesJAAD Case Reports, 2023
Morgan Zabel, BS   +5 more
doaj   +3 more sources

Pityriasis Rosea in a Woman and Her Husband – Case Report and Review of the Literature [PDF]

open access: yesCase Reports in Dermatology, 2010
Pityriasis rosea is an acute, self-limited papulosquamous dermatosis of the trunk and extremities. Many atypical forms of the disease have been reported in the literature [Ahmed et al.: Clin Exp Dermatol 2000;25:624–626; Imamura et al.: Dermatologica ...
Natalya Lemster   +2 more
doaj   +4 more sources

A Review of Pityriasis Rosea in Relation to SARS-CoV-2/COVID-19 Infection and Vaccination. [PDF]

open access: yesCureus, 2023
Pityriasis rosea (PR) is an acute exanthematous disease, commonly preceded by a primary solitary herald patch followed by the onset of smaller scaly papulosquamous lesions within days to weeks.
Wong N   +4 more
europepmc   +2 more sources

Comparative Efficacy of Different Pharmacological Treatments for Pityriasis Rosea: A Network Meta-Analysis. [PDF]

open access: yesJ Clin Med
Background/Objectives: Pityriasis rosea (PR) is a self-limiting exanthematous disease associated with the endogenous reactivation of human herpesviruses (HHV)-6 and HHV-7. Classically, the lesions gradually resolve, leaving no sequelae.
Ciccarese G   +6 more
europepmc   +2 more sources

Home - About - Disclaimer - Privacy